Paroxetine in depressed adolescents with intellectual disability: An open label study

Journal of Intellectual Disability Research

Volumn 41, Issue 3, 1997, Pages 268-272

  Masi, G ^a,b   Marcheschi, M ^a   Pfanner, P ^a  

^a DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Adolescence; Depression; Intellectual disability; Paroxetine

Indexed keywords

ANTIDEPRESSANT AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CHILD PSYCHIATRY; CLINICAL ARTICLE; DEPRESSION; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; INTELLECTUAL IMPAIRMENT; LASSITUDE; MALE; RATING SCALE; SEDATION; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0030867373     PISSN: 09642633     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2788.1997.tb00707.x     Document Type: Article

References (13)

1. Aman M., White A., Vaithiantan C. & Techan C. (1986) Preliminary study on imipramine in profoundly retarded residents. Journal of Autism and Developmental Disorders 16, 263-73.
2. Ambrosini P. J., Bianchi M. D., Rabinovich H. & Elia J. (1993) Antidepressant in children and adolescents. I. Affective disorders. Journal of the American Academy of Child & Adolescent Psychiatry 32, 1-6.
3. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC.
4. Dechant K. L. & Clissold S. P. (1991) Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs 41, 225-53.
5. Donaldson J. Y. (1984) Specific psychopharmachological approaches and rationale for mentally ill mentally retarded children. In: Handbook of Mental Illness in the Mentally Retarded (eds F. J. Menolascino & J. A. Stark), pp. 172-181. Plenum Press, New York NY.
6. Dosen A. & Gielen J. J. M. (1993) Depression in persons with mental retardation: assessment and diagnosis. In: Mental Health Aspects of Mental Retardation (R. J. Fletcher & A. Dosen) ), pp. 70-97. Lexington Books, New York, NY.
7. Ghaziuddin M., Tsai L. & Ghaziuddin N. (1991) Fluoxetine in autism with depression. Journal of the American Academy of Child & Adolescent Psychiatry 30, 508-9.
8. Masi G. (1997) Psychiatric illness in mentally retarded adolescent: clinical features. Adolescence, in press.
9. Montgomery S. A. & Asberg M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry 39, 41-5.
10. Riddle M. A., King R. A., Harding M. T., Scahill L., Ort S. I., Chapell P., Rasmussen A. & Leckman J. F. (1991) Behavioral side effects of fluoxetine in children and adolescents. Journal of Child & Adolescent Psychopharmacology 1, 193-8.
11. Rosenberg D. R., Holttum J. & Gershon S. (1994) Textbook of Pharmacotherapy for Child and Adolescent Psychiatric Disorders. Brunner/Mazel Publishers, New York, NY.
12. Sovner R., Fox C. J., Lowry M. J. & Lowry M. A. (1993) Fluoxetine treatment of depression and associated self-injury in two adults with mental retardation. Journal of Intellectual Disability Research 37, 301-11.
13. Tulloch I. F. & Johnson A. M. (1992) The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor. Journal of Clinical Psychiatry 53, 7-12.